🔗 Share this article

Chancellor Reeves has stated she is preparing "targeted action to address cost of living issues" in the forthcoming Budget.

In comments to the BBC, she stated that lowering inflation is a collective responsibility of both the administration and the Bank of England.

The UK's inflation rate is forecast to be the highest among the G7 developed nations this year and the following year.

Possible Energy Cost Interventions

Reports indicate the government could intervene to reduce utility costs, for example by reducing the current 5% level of value-added tax applied on energy.

An additional approach is to cut some of the policy costs presently included in bills.

Budgetary Limitations and Analyst Predictions

The administration will obtain the next assessment from the official forecaster, the Office for Budget Responsibility, on the start of the week, which will reveal how much room there is for such actions.

The expectation from the majority of experts is that Reeves will have to declare tax increases or spending cuts in order to adhere to her declared borrowing rules.

Previously on the same day, analysis indicated there was a £22 billion shortfall for the Treasury chief to resolve, which is at the lower end of expectations.

"There's a collective responsibility between the Bank of England and the administration to bear down further on some of the sources of price increases," Reeves told the BBC in the US capital, at the yearly gatherings of the International Monetary Fund and World Bank.

Tax Pledges and International Concerns

While a great deal of the attention has been on expected tax rises, the Treasury chief said the most recent figures from the OBR had not altered her pledge to campaign commitments not to increase tax levels on income tax, sales tax or National Insurance.

She blamed an "unpredictable world" with growing geopolitical and commercial concerns for the fiscal tax moves, likely to be focused on those "with the broadest shoulders."

International Economic Disputes

Referring to worries about the United Kingdom's commercial links with China she said: "The UK's national security always take priority."

Recent declaration by Chinese authorities to tighten trade restrictions on rare earths and other resources that are key for high-technology manufacturing led American leader the US President to suggest an extra 100% import tax on imports from China, increasing the risk of an all-out commercial conflict between the two global powers.

The US Treasury Secretary called the Chinese decision "economic coercion" and "a global supply chain control attempt."

Questioned on accepting the American proposal to join its dispute with the Asian nation, the Chancellor said she was "extremely troubled" by Chinese actions and called on the Beijing authorities "not to put up barriers and restrict access."

She said the move was "damaging for the global economy and creates additional headwinds."

"In my view there are fields where we should confront Chinese policies, but there are also important chances to export to Chinese markets, including banking sector and other areas of the economic system. We've got to get that equilibrium appropriate."

The Treasury chief also stated she was working with international partners "on our own essential resources strategy, so that we are more independent."

NHS Drug Pricing and Investment

The Chancellor also acknowledged that the price the National Health Service pays for medicines could increase as a result of ongoing talks with the US government and its pharmaceutical firms, in exchange for lower tariffs and capital.

A number of the world's largest drug companies have said lately that they are either halting or scrapping operations in the UK, with several blaming the modest returns they are getting.

Recently, the government science advisor said the price the health service pays for medicines would have to go up to prevent firms and drug research funding departing from the United Kingdom.

The Chancellor told the BBC: "It has been observed as a result of the pricing regime, that clinical trials, new drugs have not been available in the United Kingdom in the way that they are in other EU nations."

"The objective is to make sure that people getting care from the NHS are can obtain the best critical medicines in the globe. And so we are examining all of that, and... looking to attract more investment into the UK."